U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07727239) titled 'Temporal Interference Stimulation of Hypothalamus in Patients With Narcolepsy Type 1' on July 12.
Brief Summary: Narcolepsy type 1 (NT1) is a chronic brain disorder caused by selective loss or dysfunction of orexin (hypocretin) neurons in the lateral hypothalamus, for which current pharmacological treatments offer limited efficacy. Temporal interference (TI) stimulation is a recently developed noninvasive neuromodulation technique that enables focal modulation of deep brain structures. In this randomized, double-blind study, we developed a theta-burst patterned TI protocol and evaluated its effects in patients with NT1.
Study Start...